Industry Updates
This broad category includes articles concerning health insurance costs, carrier and health plan news, changing benefits technology, and surveys by the Kaiser Family Foundation and others on employee benefits.
The partnership grew out of a philosophical alignment between the companies, with each citing the desire to simplify access and pricing.
U.S. employers are bracing for the largest increase in health insurance costs in a decade next year, according forecasts from healthcare consultants, but workers may be somewhat spared this time around in a tight labor market.
The Biden administration announced Wednesday that it is providing $600 million in funding to produce new at-home COVID-19 tests and is restarting a website allowing Americans to again order up to four free tests per household — aiming to prevent possible shortages during a rise in coronavirus cases that has typically come during colder months. The Department of Health and Human ...
For employers that set their employee premium costs last year right at the ACA affordability threshold, their plans will no longer be affordable if they charge employees the same amount in 2024 as they did in 2023.
Inflation is broadly retreating in the U.S. economy. But starting in October, health insurance is poised to act as a countervailing force that buoys inflation for about a year, economists said.
The administration says insurance companies are using loopholes to deny mental health care. Insurers say that’s not the case.
The threat of a government shutdown is hanging over Capitol Hill. But so is the realization that gridlock could claim an array of health programs that are due to sunset at the end of the month without congressional action. Who’s affected: Key health interests potentially have billions of dollars of funding on the line, from community ...
Tennessee last year spent $48 million on a single drug, Humira — about $62,000 for each of the 775 patients who were covered by its employee health insurance program and receiving the treatment. So when nine Humira knockoffs, known as biosimilars, hit the market for as little as $995 a month, the opportunity for savings ...
Meg Bakewell, who has cancer and cancer-related heart disease, sometimes emails her primary care physician, oncologist, and cardiologist asking them for medical advice when she experiences urgent symptoms such as pain or shortness of breath. But she was a little surprised when, for the first time, she got a bill — a $13 copay — ...
The U.S. Food and Drug Administration (FDA) on Monday authorized updated COVID-19 vaccines from Pfizer (PFE.N)/BioNTech (22UAy.DE) and Moderna (MRNA.O) that target a recently circulating Omicron variant of the coronavirus, paving the way for the launch later this week of a fall vaccination campaign.